标题
The Use of Biologics During the COVID-19 Pandemic
作者
关键词
COVID-19, Biologics, Psoriasis, Atopic dermatitis, Hidradenitis suppurativa, TNF-Inhibitor, IL inhibitor, Dupilumab
出版物
DERMATOLOGIC CLINICS
Volume 39, Issue 4, Pages 545-553
出版商
Elsevier BV
发表日期
2021-06-01
DOI
10.1016/j.det.2021.05.010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dupilumab and COVID ‐19: What should we expect?
- (2020) Cataldo Patruno et al. Dermatologic Therapy
- Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
- (2020) April W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
- (2020) Ulrike Förster-Ruhrmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
- (2020) Alecia Blaszczak et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
- (2020) Paolo Gisondi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic
- (2020) Marilyn T. Wan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- SARS‐CoV‐2 asymptomatic infection in a patient under treatment with dupilumab
- (2020) Francesca Caroppo et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports
- (2020) S. Ferrucci et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The risk of respiratory tract infections and interstitial lung disease with IL-12/23 and IL-23 antagonists in patients with autoimmune diseases: a systematic review and meta-analysis
- (2020) Shintaro Akiyama et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
- (2020) Jesse Veenstra et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic
- (2020) Donovan G. Kearns et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Factors associated with adverse COVID-19 outcomes in patients with psoriasis – insights from a global registry-based study
- (2020) Satveer K. Mahil et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in psoriasis patients - A meta-estimate of pivotal phase 3 trials relevant to decision-making during the COVID-19 pandemic
- (2020) Maha N. Syed et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
- (2020) Joel M. Gelfand et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now